Artisan Partners, an investment management company, released its “Artisan Value Fund” first quarter 2025 investor letter. A ...

In its first quarter 2025 investor letter, Andvari Associates emphasized stocks such as Philip Morris International Inc. (NYSE:PM). Philip Morris International Inc. (NYSE:PM) tobacco company ...

Broyhill Asset Management highlighted stocks like Philip Morris International Inc. (NYSE:PM) in the second quarter 2024 investor letter. Philip Morris International Inc. (NYSE:PM) tobacco company ...

Much of the latter is going to increased capacity ... Geoffrey Seiler has positions in Philip Morris International. The Motley Fool recommends Philip Morris International. The Motley Fool has ...

Broyhill Asset Management highlighted stocks like Philip Morris International Inc. (NYSE:PM) in the Q4 2022 investor letter. Headquartered in Stamford, Connecticut, Philip Morris International Inc ...

Andvari Associates highlighted stocks like Philip Morris International Inc. (NYSE:PM) in the second quarter 2024 investor letter. Philip Morris International Inc. (NYSE:PM) tobacco company working ...

Philip Morris International (NYSE ... Philip Morris was spun off by Altria so the latter could focus entirely on the North American market. If you are looking at these two stocks with the idea ...

sending letters to regulators accusing the company of misrepresenting past regulatory decisions, the news outlet continued. In the meantime, Philip Morris continues to wait on FDA approval for its ...

Philip Morris International recently announced that it ... editorials and more. To send a letter to the editor about this article, submit online or check out our guidelines for how to submit ...

Data source: Philip Morris International. It expects to generate about $11 billion in operating cash flow while spending $1.4 billion on capital expenditures. Much of the latter is going to ...

However, Philip Morris International (NYSE ... flow while spending $1.4 billion on capital expenditures. Much of the latter is going to increased capacity in the U.S. for Zyn.